[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100435229":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":25,"locations":31,"responsibleParty":47,"collaborators":24,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":60,"sex":61,"minAge":62,"maxAge":63,"enrollmentInfo":64,"targetDuration":24,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":24,"overallStatus":74,"whyStopped":24,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"University of Milan","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Bioarginina C","ACTIVE_COMPARATOR","vials based on L-arginine and liposomal vitamin C",[13],"Dietary Supplement: Bioarginina C",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","vials without L-arginine and liposomal vitamin C",[13],[20],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":24},"DIETARY_SUPPLEMENT","Dietary supplement vials",[9,15],null,[26],{"name":27,"role":28,"phone":29,"phoneExt":29,"email":30},"barbara maglione","CONTACT","+393343293357","barbara.maglione@farmadamor.it",[32],{"facility":33,"status":34,"city":35,"state":24,"zip":24,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Barbara Maglione","RECRUITING","Naples","Italy","IT",{"type":39,"coordinates":40},"Point",[41,42],14.26811,40.85216,{"lat":42,"lon":41},[45],{"name":46,"role":28,"phone":29,"phoneExt":29,"email":30},"barbara o maglione",{"type":48,"investigatorFullName":49,"investigatorTitle":50,"investigatorAffiliation":51,"oldNameTitle":24,"oldOrganization":24},"PRINCIPAL_INVESTIGATOR","Matteo Tosato","Doctor","Fondazione Policlinico Universitario Agostino Gemelli IRCCS","100435229","evaluation-of-the-effects-of-treatment-with-bioarginin-c-in-adult-subjects-belonging-to-the-post-covid-day-hospital-100435229",false,"NCT04947488","Evaluation of the Effects of Treatment With Bioarginin C in Adult Subjects Belonging to the Post-Covid Day Hospital","Evaluation of the Effects of Treatment With Bioarginin C on Physical Exhaustion , Systemic Inflammatory State and Endothelial Function in Adult Subjects Belonging to the Post-Covid Day Hospital","BC","Inclusion Criteria:\n\nsubjects with proven positivity to the molecular test for Sars-cov2 with demonstration of microbiological healing patients discharged from FPG or other hospital structures; or only contact in PS; or home management age: range 20-60 years Fatigue operationalized as an affirmative answer to item \"7\" (CES-D)\n\nExclusion Criteria:\n\nPharmacological therapies with possible interactions with the mechanisms \u002F processes under study (e.g. antihypertensive drugs, cortisone drugs, NSAIDs, immunosuppressants, nitrates)",true,"ALL","20 Years","60 Years",{"count":65,"type":66},50,"ESTIMATED","INTERVENTIONAL",[69],"NA","Long Covid could be much more frequent than it is thought to be. Few dwell on the great problem represented by the post covid syndrome. The virus often leaves important marks on our body, and those who recover face problems of various kinds: chronic fatigue, shortness of breath, dry cough, headache, cognitive difficulties.\n\nOn the duration and resolution of this syndrome, now recognized as a highly debilitating condition, there are still no great answers: for this reason it is always important to emphasize that contracting Covid, even in a not serious form, still means exposing oneself to long-term risks that are still not well codified by the scientific community. Guidelines and more tools are expected to best assist these patients.",[72,73],"Fatigue Syndrome, Chronic","Inflammation","UNKNOWN","2022-05-16",{"date":77,"type":78},"2022-05-17","ACTUAL",{"date":80,"type":78},"2021-06-18",{"date":82,"type":66},"2022-11-18",{"name":5,"class":6},1]